These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7238955)

  • 61. Antigens of the surface of mouse ascites tumour cells. I. Studies with rabbit anti-mouse cell sera.
    Boyle W; Davies DA
    Immunology; 1966 Oct; 11(4):353-9. PubMed ID: 5924620
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Radiotherapy and immune reactions of spleen cells in experimental tumors].
    Juliani G; Cirillo R; Ballaira L; Fava C
    Minerva Radiol; 1969 Nov; 14(11):494-8. PubMed ID: 5383669
    [No Abstract]   [Full Text] [Related]  

  • 63. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1596-600. PubMed ID: 16185524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 66. Characteristics of a xenogeneic lymphocyte transfer reaction: its use in the study of graft versus host capability of mouse lymphoid cells from various anatomic sites.
    Catanzaro PJ; Graham RC; Powell AE; Phillips SM
    Cell Immunol; 1976 Mar; 22(1):140-51. PubMed ID: 6151
    [No Abstract]   [Full Text] [Related]  

  • 67. Assessment of combined thymus and hematopoietic tissue xenografts for the induction of xenogeneic microchimerism in NOD mice.
    Simeonovic CJ; Townsend MJ; Teittinen KU; Groves JC; Wilson JD
    Transplant Proc; 1995 Feb; 27(1):160-3. PubMed ID: 7878955
    [No Abstract]   [Full Text] [Related]  

  • 68. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
    Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
    Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
    [No Abstract]   [Full Text] [Related]  

  • 69. Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei.
    Zitnan D; Cebecauer L; Ujházy V
    Neoplasma; 1969 Jun; 16(3):339-41. PubMed ID: 4981697
    [No Abstract]   [Full Text] [Related]  

  • 70. [The immunologic reactivity of mice with the ascitic form of Ehrlich carcinoma].
    Botev B; Markholev L
    Biull Eksp Biol Med; 1969 Dec; 68(12):70-1. PubMed ID: 5382331
    [No Abstract]   [Full Text] [Related]  

  • 71. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 72. Mixed lymphocyte reaction and skin graft using HLA-DP and DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Aug; 26(4):1868. PubMed ID: 8066607
    [No Abstract]   [Full Text] [Related]  

  • 73. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 74. [Immunotherapy of Ehrlich ascites tumor in mice].
    Jakóbisiak M
    Pol Arch Med Wewn; 1980 May; 63(5):503-9. PubMed ID: 7413475
    [No Abstract]   [Full Text] [Related]  

  • 75. Fully and long-term xenogeneic hematopoietic chimeras created in poorly concordant rat-mouse combinations: expression of hereditary donor characteristics.
    Spach C; Lucchiari N; Bureaud N; Motta R
    Exp Hematol; 1995 Oct; 23(11):1192-203. PubMed ID: 7556530
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Phytohaemagglutinin (PHA) induced cytotoxicity II: The effect of PHA stimulated spleen cells to Erlich tumor cells in vivo (author's transl)].
    Aoki S
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1404-11. PubMed ID: 739705
    [No Abstract]   [Full Text] [Related]  

  • 78. On the role of interleukin-10 in the induction and maintenance of specific transplantation tolerance.
    Holán V; Kosarová M; Lipoldová M
    Folia Biol (Praha); 1994; 40(6):381-94. PubMed ID: 7589697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of ultraviolet irradiation on the localization of syngeneic and allogeneic lymphoid cells and on alloimmunogenicity.
    Milton JD
    Immunology; 1981 Oct; 44(2):281-7. PubMed ID: 7298068
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Titration of cytolytic antitumor antibody utilizing absorbance at 260 m-mu to measure the leakage of cell constituents.
    Nungester WJ; Adair JA; Allardyce RA; Paradise LJ
    Cancer Res; 1969 Jun; 29(6):1262-6. PubMed ID: 5797109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.